TechnipFMC heads into its July 23 results with short sellers quietly rebuilding positions into a stock trading near multi-month highs — creating a modest but sharpening tension worth tracking.
The most notable development this week is the pace of short interest growth. Shorts added around 35% more exposure over the past month, with SI % of FF climbing from roughly 2.4% in late May to 3.8% now. That monthly move of 15% is the most meaningful directional shift in the data. The weekly build of 8.7% confirms the trend has continued into early July. This isn't a crowded short — 3.8% of float is a modest absolute level — but the trajectory is deliberate, arriving precisely as the stock has recovered to $68.11 and earnings loom two weeks out. Borrowing costs remain low at 0.57%, up about 15% on the week but still well within "easy to borrow" territory. Availability is exceptionally loose at over 2,000% of short interest, meaning there is no constraint on new short positioning. The lending market presents no friction for anyone wanting to press the trade.
Options positioning has shifted slightly more defensive than usual. The put/call ratio is running at 0.45, modestly above its 20-day average of 0.39 with a z-score near 1.2 — not extreme, but the highest the ratio has been in roughly six weeks. It's well below the 52-week high of 0.64, so this is a lean rather than a hedge-heavy setup. The combination of rising short interest and a gently elevated PCR suggests investors are adding modest downside protection ahead of the print rather than expressing high conviction either way.
The Street remains broadly constructive, but Susquehanna cut its target this week from $90 to $85 while holding its Positive rating — the first downward move after a series of post-Q1 upgrades from Barclays, Citigroup, and Evercore ISI, all of which had lifted targets into the $80-$87 range following April results. The analyst consensus sits at hold, with a mean target of $75.81 — implying the stock at $68 still offers meaningful upside to consensus but has already retraced past several recent targets. Valuation has compressed slightly; the PE has declined about 2.5 turns over the past 30 days, now near 20x, while EV/EBITDA sits around 11.5x. The bull case centres on TechnipFMC's record Subsea EBITDA margin of 21.8% and management's raised 2026 guidance of 20.5-22%, alongside strong free cash flow. Bears point to execution risk — historical margin pressure in offshore wind and competitive pricing dynamics — as the core vulnerability.
Insider activity from earlier in the year is worth noting as context. The CEO sold roughly $35 million in stock across two transactions in early March when the share price was in the low-$60s range, alongside material sales by the CFO and other executives. Those sales came near what proved to be a relative low, with the stock since recovering toward $68-$74. The recent trades in May were much smaller director-level sells, and there have been no notable purchases.
Earnings history adds a mixed data point. Last April the stock fell 1.6% the day after results and extended that to -7.7% by day five. The prior print in late January produced a 3.5% gain on the day. With short interest rebuilding and the PCR drifting higher into the July 23 release, the question is whether the Subsea margin story can once again surprise to the upside — or whether the recent target trim from Susquehanna signals more cautious expectations are setting in ahead of the number.
See the live data behind this article on ORTEX.
Open FTI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
